Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Val R Adams

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Molecular and Cellular Biochemistry|April 19, 2003
L-Canavanine as a radiosensitization agent for human pancreatic cancer cellsAimee K Bence, Val R Adams, Peter A Crooks
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 30, 2017
Association of hypertension and treatment outcomes in advanced stage non-small cell lung cancer patients treated with bevacizumab or non-bevacizumab containing regimensLily Z Yan, Emily V Dressler, Val R Adams
Pharmacotherapy|January 29, 2013
The reversal of inhibitors in congenital hemophiliaSean R DeFrates, Kevin T McDonagh, Val R Adams
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 29, 2014
Optimizing postgraduate year 3 trainingAlexander H Flannery, Val R Adams, David S Burgess
Orthopedics|September 2, 2010
Complications associated with treatment of malignancies: a focus on avascular necrosis of the boneAshley M Newland, Amber P Lawson, Val R Adams
Healthcare (Basel, Switzerland)|December 22, 2016
Impact of Time-Varying Treatment Exposures on the Risk of Venous Thromboembolism in Multiple MyelomaJoshua D Brown, Val R Adams, Daniela C Moga
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 23, 2020
Afatinib for the treatment of <i>EGFR</i> mutation-positive NSCLC: A review of clinical findingsR Donald Harvey, Val R Adams, Tyler Beardslee, et al.
Antimicrobial Agents and Chemotherapy|May 18, 2011
Pharmacokinetics of intravenous levofloxacin administered at 750 milligrams in obese adultsAaron M Cook, Craig Martin, Val R Adams, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 15, 2015
Capecitabine-induced ventricular fibrillation arrest: Possible Kounis syndromeKazuhiko Kido, Val R Adams, Richard S Morehead, et al.
Orthopedics|December 17, 2009
Osteonecrosis of the jaw associated with bisphosphonate therapyScott M Wirth, Amber P Lawson, Stephanie D Sutphin, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Molecular and Cellular Biochemistry|April 19, 2003
L-Canavanine as a radiosensitization agent for human pancreatic cancer cellsAimee K Bence, Val R Adams, Peter A Crooks
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 30, 2017
Association of hypertension and treatment outcomes in advanced stage non-small cell lung cancer patients treated with bevacizumab or non-bevacizumab containing regimensLily Z Yan, Emily V Dressler, Val R Adams
Pharmacotherapy|January 29, 2013
The reversal of inhibitors in congenital hemophiliaSean R DeFrates, Kevin T McDonagh, Val R Adams
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 29, 2014
Optimizing postgraduate year 3 trainingAlexander H Flannery, Val R Adams, David S Burgess
Orthopedics|September 2, 2010
Complications associated with treatment of malignancies: a focus on avascular necrosis of the boneAshley M Newland, Amber P Lawson, Val R Adams
Healthcare (Basel, Switzerland)|December 22, 2016
Impact of Time-Varying Treatment Exposures on the Risk of Venous Thromboembolism in Multiple MyelomaJoshua D Brown, Val R Adams, Daniela C Moga
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 23, 2020
Afatinib for the treatment of <i>EGFR</i> mutation-positive NSCLC: A review of clinical findingsR Donald Harvey, Val R Adams, Tyler Beardslee, et al.
Antimicrobial Agents and Chemotherapy|May 18, 2011
Pharmacokinetics of intravenous levofloxacin administered at 750 milligrams in obese adultsAaron M Cook, Craig Martin, Val R Adams, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 15, 2015
Capecitabine-induced ventricular fibrillation arrest: Possible Kounis syndromeKazuhiko Kido, Val R Adams, Richard S Morehead, et al.
Orthopedics|December 17, 2009
Osteonecrosis of the jaw associated with bisphosphonate therapyScott M Wirth, Amber P Lawson, Stephanie D Sutphin, et al.
Pageof 4